The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection
Background: Individuals infected with the COVID-19 virus present with different symptoms of varying severity. In addition, not all individuals are infected despite exposure. Risk factors such as age, sex, and comorbidities play a major role in this variability; however, genetics may also be importan...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.798571/full |
_version_ | 1818971192851169280 |
---|---|
author | Halim Saad Karna Jabotian Carine Sakr Rami Mahfouz Imad Bou Akl Nathalie K. Zgheib |
author_facet | Halim Saad Karna Jabotian Carine Sakr Rami Mahfouz Imad Bou Akl Nathalie K. Zgheib |
author_sort | Halim Saad |
collection | DOAJ |
description | Background: Individuals infected with the COVID-19 virus present with different symptoms of varying severity. In addition, not all individuals are infected despite exposure. Risk factors such as age, sex, and comorbidities play a major role in this variability; however, genetics may also be important in driving the differences in the incidence and prognosis of the disease. An Insertion/Deletion (I/D) polymorphism in the ACE1 gene (rs1799752) may explain these genetic differences. The aims of this study were to determine the potential role of ACE1 I/D genetic polymorphism in the risk of contracting COVID-19 as well as predicting the severity of COVID-19 infection.Methods: Three-hundred and eighty-seven non-related Lebanese subjects, 155 controls and 232 cases, who presented to the American University of Beirut Medical Center (AUBMC) for COVID-19 PCR testing were recruited. Clinical data were collected via filling a questionnaire and accessing the medical records. Peripheral blood was withdrawn for DNA isolation, and genotyping performed with standard PCR followed by band visualization on agarose gel.Results: In our study population, previously described risk factors such as gender, age, and comorbidities were associated with increase in disease susceptibility and severity. ACE1 I was the least common allele, and there was a positive association between ACE1 I and the risk of contracting the COVID-19 disease. More specifically, the frequency of II genotype was significantly higher among cases when compared to controls (P = 0.035) with individuals with the II genotype having greater risk for contracting the COVID-19 disease: OR = 2.074, P = 0.048 in the multivariate analysis. As for disease severity, the DD genotype and D allele were associated with increased risk for developing severe symptoms (OR = 2.845, P = 0.026 and OR = 2.359, P = 0.014, respectively), and the DD genotype with necessitating hospitalization (OR = 2.307, P = 0.042). In parallel, D allele carriers showed a significantly increased risk for developing hypoxia: OR = 4.374, P = 0.045.Conclusion: We found a positive association between ACE1 I and the risk of contracting the COVID-19 disease, and between ACE1 D and a worse outcome of the COVID-19 infection. Therefore, genotyping for ACE1 I/D polymorphism could be used to assess risk and predict severity for better prognosis and management of the disease. |
first_indexed | 2024-12-20T14:48:28Z |
format | Article |
id | doaj.art-fbc3ec5dcc6541488279b7987a2f568a |
institution | Directory Open Access Journal |
issn | 2296-858X |
language | English |
last_indexed | 2024-12-20T14:48:28Z |
publishDate | 2021-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Medicine |
spelling | doaj.art-fbc3ec5dcc6541488279b7987a2f568a2022-12-21T19:37:03ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-12-01810.3389/fmed.2021.798571798571The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 InfectionHalim Saad0Karna Jabotian1Carine Sakr2Rami Mahfouz3Imad Bou Akl4Nathalie K. Zgheib5Department of Pharmacology and Toxicology, American University of Beirut Faculty of Medicine, Beirut, LebanonDepartment of Pharmacology and Toxicology, American University of Beirut Faculty of Medicine, Beirut, LebanonEmployee Health Unit, Department of Family Medicine, American University of Beirut Faculty of Medicine, Beirut, LebanonDepartment of Pathology and Laboratory Medicine, American University of Beirut Faculty of Medicine, Beirut, LebanonDivision of Pulmonary, Department of Internal Medicine, American University of Beirut Faculty of Medicine, Beirut, LebanonDepartment of Pharmacology and Toxicology, American University of Beirut Faculty of Medicine, Beirut, LebanonBackground: Individuals infected with the COVID-19 virus present with different symptoms of varying severity. In addition, not all individuals are infected despite exposure. Risk factors such as age, sex, and comorbidities play a major role in this variability; however, genetics may also be important in driving the differences in the incidence and prognosis of the disease. An Insertion/Deletion (I/D) polymorphism in the ACE1 gene (rs1799752) may explain these genetic differences. The aims of this study were to determine the potential role of ACE1 I/D genetic polymorphism in the risk of contracting COVID-19 as well as predicting the severity of COVID-19 infection.Methods: Three-hundred and eighty-seven non-related Lebanese subjects, 155 controls and 232 cases, who presented to the American University of Beirut Medical Center (AUBMC) for COVID-19 PCR testing were recruited. Clinical data were collected via filling a questionnaire and accessing the medical records. Peripheral blood was withdrawn for DNA isolation, and genotyping performed with standard PCR followed by band visualization on agarose gel.Results: In our study population, previously described risk factors such as gender, age, and comorbidities were associated with increase in disease susceptibility and severity. ACE1 I was the least common allele, and there was a positive association between ACE1 I and the risk of contracting the COVID-19 disease. More specifically, the frequency of II genotype was significantly higher among cases when compared to controls (P = 0.035) with individuals with the II genotype having greater risk for contracting the COVID-19 disease: OR = 2.074, P = 0.048 in the multivariate analysis. As for disease severity, the DD genotype and D allele were associated with increased risk for developing severe symptoms (OR = 2.845, P = 0.026 and OR = 2.359, P = 0.014, respectively), and the DD genotype with necessitating hospitalization (OR = 2.307, P = 0.042). In parallel, D allele carriers showed a significantly increased risk for developing hypoxia: OR = 4.374, P = 0.045.Conclusion: We found a positive association between ACE1 I and the risk of contracting the COVID-19 disease, and between ACE1 D and a worse outcome of the COVID-19 infection. Therefore, genotyping for ACE1 I/D polymorphism could be used to assess risk and predict severity for better prognosis and management of the disease.https://www.frontiersin.org/articles/10.3389/fmed.2021.798571/fullACE1COVIDriskseveritygenetic polymorphism |
spellingShingle | Halim Saad Karna Jabotian Carine Sakr Rami Mahfouz Imad Bou Akl Nathalie K. Zgheib The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection Frontiers in Medicine ACE1 COVID risk severity genetic polymorphism |
title | The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection |
title_full | The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection |
title_fullStr | The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection |
title_full_unstemmed | The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection |
title_short | The Role of Angiotensin Converting Enzyme 1 Insertion/Deletion Genetic Polymorphism in the Risk and Severity of COVID-19 Infection |
title_sort | role of angiotensin converting enzyme 1 insertion deletion genetic polymorphism in the risk and severity of covid 19 infection |
topic | ACE1 COVID risk severity genetic polymorphism |
url | https://www.frontiersin.org/articles/10.3389/fmed.2021.798571/full |
work_keys_str_mv | AT halimsaad theroleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT karnajabotian theroleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT carinesakr theroleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT ramimahfouz theroleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT imadbouakl theroleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT nathaliekzgheib theroleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT halimsaad roleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT karnajabotian roleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT carinesakr roleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT ramimahfouz roleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT imadbouakl roleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection AT nathaliekzgheib roleofangiotensinconvertingenzyme1insertiondeletiongeneticpolymorphismintheriskandseverityofcovid19infection |